Thermo Fisher Scientific Inc.TMONYSE
Loading
Revenue Growth AcceleratingAccelerating
Percentile Rank79
3Y CAGR+10.7%
5Y CAGR-16.2%
Year-over-Year Change
Year-over-year revenue growth rate
3Y CAGR
+10.7%/yr
Quarterly compound
5Y CAGR
-16.2%/yr
Recent acceleration
Percentile
P79
Within normal range
vs 5Y Ago
0.4x
Contraction
Streak
1 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 9.83% |
| Q3 2025 | 2.46% |
| Q2 2025 | 4.74% |
| Q1 2025 | -9.05% |
| Q4 2024 | 7.52% |
| Q3 2024 | 0.54% |
| Q2 2024 | 1.89% |
| Q1 2024 | -4.97% |
| Q4 2023 | 2.95% |
| Q3 2023 | -1.06% |
| Q3 2023 | -0.21% |
| Q2 2023 | -6.46% |
| Q4 2022 | 7.24% |
| Q4 2022 | -2.67% |
| Q3 2022 | -7.18% |
| Q2 2022 | 10.43% |
| Q4 2021 | 14.71% |
| Q4 2021 | 0.61% |
| Q3 2021 | -6.39% |
| Q2 2021 | -6.10% |
| Q4 2020 | 23.81% |
| Q3 2020 | 23.19% |
| Q2 2020 | 11.03% |
| Q1 2020 | -8.77% |
| Q4 2019 | 8.88% |
| Q3 2019 | -0.70% |
| Q2 2019 | 3.12% |
| Q1 2019 | -5.87% |
| Q4 2018 | 9.92% |
| Q3 2018 | -2.60% |
| Q2 2018 | 3.84% |
| Q1 2018 | -3.21% |
| Q4 2017 | 18.19% |
| Q3 2017 | 2.53% |
| Q3 2017 | 4.72% |
| Q2 2017 | -3.80% |
| Q4 2016 | 10.29% |
| Q4 2016 | -0.98% |
| Q3 2016 | 5.60% |
| Q2 2016 | -7.69% |